Skip to main content
. 2024 Sep 5;24:249. doi: 10.1186/s12893-024-02551-8

Table 2.

Surgical outcomes and Oncologic clearance of all patients

Unmatched cohort (n = 105)
Variables RPSS group ( n = 26 ) EC group ( n = 79 ) p value
Surgical outcomes
 Surgical technique
  Sigmoidectomy/AR/LAR/SLAR 4/8/7/7 6/17/30/26 0.54
   Ileostomy N (%) 9 (35) 29 (37) 1.0
Total operation times
 All surgical techniquesa min 294 (131) 340 (193) 0.19
 Sigmoidectomy, ARa min 256 (90) 242 (100) 1.0
 LARa min 326 (213) 373 (113) 0.62
 SLARa min 361 (154) 517 (280) 0.064
 Blood lossb mL 5 (9.5) 19 (40) 0.014
 Length of umbilical incisionb mm 29 (0.57) 31 (0.63) 0.047
 Leak test positive N (%) 0 (0) 0 (0)
Oncologic clearance
 Number of lymph nodes harvesteda 15 (8.5) 17 (13) 0.34
 Lateral lymph node dissection N (%) 3 (12) 11 (14) 1.0
 CRM positive N (%) 0 (0) 1 (1.3) 1.0
pStaging
  0/I/II/III/IV 0/10/7/7/2 1/27/24/23/4 0.94
Matched cohort after a 1:1 Propensity score matching (n = 46)
 Variables RPSS group ( n = 23 ) EC group ( n = 23 ) p value
Surgical outcomes
 Surgical technique
  Sigmoidectomy/AR/LAR/SLAR 4/7/6/6 4/6/5/8 0.93
  Ileostomy N (%) 7 (30) 9 (39) 0.54
Total operation times
 All surgical techniquesa min 293 (116) 337 (279) 0.36
 Sigmoidectomy, ARa min 268 (96) 252 (106) 0.86
 LARa min 279 (143) 334 (180) 0.58
 SLARa min 401 (210) 649 (309) 0.045
 Blood lossb mL 5.3 (10) 23 (36) 0.038
 Length of umbilical incisionb mm 30 (0.56) 32 (0.53) 0.15
 Leak test positive N (%) 0 (0) 0 (0)
Oncologic clearance
 Number of lymph nodes harvesteda 16 (9) 19 (18) 0.21
 Lateral lymph node dissection N (%) 2 (8.7) 6 (26) 0.11
 CRM positive N (%) 0 (0) 0 (0)
pStaging
  0/I/II/III/IV 0/9/6/7/1 0/8/9/6/0 0.63

AR Anterior resection, LAR Low anterior resection, SLAR Super low anterior resection, CRM Circumferential resection margin

aValues are median (IQR)

bValues are mean (SD)